A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
Condition: Asthma Interventions: Drug: Albuterol eMDPI DS; Drug: albuterol Sponsor: Teva Branded Pharmaceutical Products, R&D Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials